Clinical trials

There is no admitted medication for many molecular mutations. Participating in a clinical trial is often the only possibility to be treated with new medicine.

The NGM main office in Cologne offers you the study program of the Lung Cancer Group Cologne. For more information or questions please contact us.
lungenkrebs@uk-koeln.de

Last update: 17. March 2016 , 9:48

Molecular diagnostics

As the first group in Europe, the Network Genomic Medicine has offered a comprehensive analysis of tumor material since 2012. By means of a multiplex-test in combination with highly sensitive deep sequencing even rare gene mutations in the smallest tissue samples are detected reliably
Diagnostics
w

Second opinion

Do you have questions about your disease or your current therapy? Or maybe you would like to know if for you a personalized treatment approach or immunotherapy might be considered. Please feel free to contact us!
Second Opinion
n

Clinical trials

At the Network Genomic Medicine we try to offer an appropriate clinical trial testing a new drug to all our patients who have a detected mutation, for which there has no drug been approved for treatment yet. For that we work closely together with the Lung Cancer Group Cologne.
Trials